Jason S. Lewis: Publications

The Jason Lewis Lab
Research Overview
Featured News
Publications

Jason S. Lewis: Publications

Share
Share

Nagle VL, Henry KE, Hertz CAJ, Graham MS, Campos C, Parada LF, Pandit-Taskar N, Schietinger A, Mellinghoff IK, Lewis JS. Imaging Tumor-Infiltrating Lymphocytes in Glioblastoma with [64Cu]Cu-NOTA-anti-CD8-PET. Clinical Cancer Research, 27, 1958-1966, 2021.

Sharma SK, Suzuki M, Xu H, Korsen JA, Samuels Z, Guo H, Nemieboka B, Piersigilli A, Edwards KJ, Cheung NKV, Lewis JS. Influence of Fc modifications on biodistribution of humanized antibodies targeting L1CAM. Journal of Nuclear Medicine, 63, 629-636, 2022.

Tully KM, Tendler S, Carter LM, Sharma SK, Samuels ZV, Mandleywala K, Korsen JA, Delos Reyes AM, Piersigilli A, Travis WD, Sen T, Pillarsetty N, Poirier JT, Rudin CM, Lewis JS. Radioimmunotherapy Targeting Delta-like Ligand 3 in Small Cell Lung Cancer Exhibits Antitumor Efficacy with Low Toxicity. Clinical Cancer Research, 28, 1391-1401, 2022.

Korsen JA, Kalidindi TM, Khitrov S, Samuels ZV, Chakraborty G, Gutierrez JA, Poirier JT, Rudin CM, Chen Y, Morris MJ, Pillarsetty NVK, Lewis JS. Molecular imaging of Neuroendocrine Prostate Cancer by targeting Delta-like Ligand-3. Journal of Nuclear Medicine, 63, 1401-1407, 2022.

Pereira PMR, Mandleywala K, Monette S, Lumish M, Tully KM, Panikar SS, Cornejo M, Mauguen A, Ragupathi A, Keltee NC, Mattar M, Janjigian YY, Lewis JS. Caveolin-1 temporal modulation enhances antibody drug efficacy in heterogeneous gastric cancer. Nature Communications, 13, 2526, 2022.

Korsen JS, Gutierrez JA, Tully KM, Carter LM, Samuels ZV, Khitrov S, Poirier JT, Rudin CM, Chen Y, Morris MJ, Bodei L, Pillarsetty NVK, Lewis JS. Delta-like Ligand 3-Targeted Radioimmunotherapy for Neuroendocrine Prostate Cancer. Proceedings of the National Academy of Sciences (PNAS), 119, e2203820119, 2022.

Rao Y, Samuels Z, Carter LM, Monette S, Panikar SS, Pereira PMR, Lewis JS. Statins enhance the efficacy of HER2-targeting radioligand therapy in drug-resistant gastric cancers. Proceedings of the National Academy of Sciences (PNAS), 120, e2220413120, 2023

Bauer D, Carter LM, Atmane MI, De Gregorio R, Michel A, Kaminsky S, Monette S, Li M, Schultz MK, Lewis JS. 212Pb-Pretargeted Theranostics for Pancreatic Cancer. Journal of Nuclear Medicine, 65, 109-116, 2024.